SPAG5 and cancer: Additionally, in 2020, Ji et al. demonstrated the potential of targeting SPAG5 for cancer treatment and concluded that an innovative approach to cancer treatment, particularly in reversing chemoresistance, could include SPAG5 antagonism (He et al. 2020).